Lead researcher Carrie Lucas, associate professor of immunobiology...
Category:
Health
Latest
Cigarette butts leak deadly toxins into environment, study finds
"The filter is full of thousands of toxic chemicals and...
Talking over mobile for more than 30 minutes linked to developing hypertension
“It’s the number of minutes people spend talking on a mobile that...
Indian economy contracts 7.5 pc in Q2, recovery seen next year
Economists have marginally raised growth forecasts this month after a pick-up in consumer demand for autos, non-durables and rail freight during the festival season.
“The possibility of a release of several highly effective vaccines soon gives us hope that there is an end date to the pandemic Rumki Majumdar, economist at Deloitte India, while expressing confidence in a quick economic rebound.
Fiscal deficit at 120 pc of annual target at October-end
The deficit widened mainly on account of poor revenue realisation. The lockdown imposed to curb spreading of coronavirus infections had significantly impacted business activities and in turn contributed to sluggish revenue realisation.
The fiscal deficit at the end of September 2020 was about 114.8 per cent of the annual budget estimate.
International passenger flights to remain suspended till December 31
However, these restrictions won’t apply to cargo operations and services approved by the DGCA.
The DGCA also added that select international flights on limited routes may be allowed by competent authorities on case to case basis.
Mamata announces health scheme for all in WB
The scheme, officially launched by Banerjee in December 2016 is a basic health cover for secondary and tertiary care up to Rs five lakh per annum per family.
India records 44,489 new coronavirus cases
The active cases comprise 4.88 per cent of the total caseload, the data stated.
The total number of people who have recuperated from the disease surged to 86,79,138, pushing the national recovery rate to 93.66 per cent, while the Covid-19 case fatality rate stands at 1.46 per cent.
Govt launches ‘Mission Covid Suraksha’ to help accelerate vaccine candidates
The mission envisages Covid-19 vaccine development with end-to-end focus from preclinical through clinical development and manufacturing and regulatory facilitation, the DBT said.
Earlier this month, the government had announced a package of Rs 900 crore for vaccines.
Phase-3 trial of Bharat Biotech’s Covaxin commences in AIIMS
Besides, Covaxin, four other vaccines are under different phases of clinical trial in India with the Serum Institute of India conducting phase-three trial of the Oxford-Astrazeneca Covid-19 vaccine while the indigenously developed vaccine by Zydus Cadila has completed phase-two clinical trial in the country.
Over 50,000 Ayushman Bharat Health and Wellness Centres operational across country
AstraZeneca faces more Covid-19 vaccine questions after manufacturing error
In a statement, Oxford said a difference in manufacturing processes led to later phases of the trials having a half-dose given instead of a full one. When it was apparent that a lower dose was used, it was discussed with regulators, and an agreement was reached to push ahead with the two regimens, the statement said.
The biggest threat to Covid-19 vaccination could be fake news and misinformation
“The coronavirus disease is the first pandemic in history in which technology and social media are being used on a massive scale to keep people safe, informed, productive and connected,” the WHO said.
“At the same time, the technology we rely on to keep connected and informed is enabling and amplifying an infodemic that continues to undermine the global response and jeopardises measures to control the pandemic.”